share_log

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

DowjonesNews MarketWatch ·  2021/11/10 16:51

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Quest Diagnostics Inc. (DGX) rose 1.94% to $144.78 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.82% to 4,646.71 and Dow Jones Industrial Average falling 0.66% to 36,079.94. Quest Diagnostics Inc. closed $15.78 short of its 52-week high ($160.56), which the company reached on September 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Laboratory Corp. of America Holdings (LH) rose 2.64% to $283.84, Qiagen N.V. (QGEN) rose 0.28% to $53.25, and Sonic Healthcare Ltd. ADR fell 1.20% to $28.86. Trading volume (963,032) remained 356,500 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 10, 2021.

-MarketWatch Automation

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする